Randomized phase II trial of chemoradiotherapy with S ‐1 versus combination chemotherapy with gemcitabine and S‐1 as neoadjuvant treatment for resectable pancreatic cancer (JASPAC 04)

ConclusionBoth NAC-RT with S-1 and NAC-GS are considered promising treatments for resectable pancreatic cancer.

https://onlinelibrary.wiley.com/doi/10.1002/jhbp.1353?af=R

Source: Journal of Hepato-Biliary-Pancreatic Sciences - September 25, 2023 Category: Gastroenterology Authors: Teiichi Sugiura, Hirochika Toyama, Akira Fukutomi, Hirofumi Asakura, Yuriko Takeda, Kouji Yamamoto, Satoshi Hirano, Sohei Satoi, Ippei Matsumoto, Shinichiro Takahashi, Soichiro Morinaga, Makoto Yoshida, Yasunaru Sakuma, Hidetaka Iwamoto, Yas Tags: ORIGINAL ARTICLE Source Type: research